The Ministry of Health calls for the combination of the first vaccine against Chiconia to Sus | health
After the approval of the first Chiconia vaccine by the National Health Control Agency (AnVisa), the Ministry of Health announced on Tuesday, 5, which will require the integration of immunity into the unified health system (SUS).
The request will be sent to the National Committee for Technologies in Sus (Con strife), which will evaluate the possibility of submitting the vaccine in the public network. The deadline for the conclusion of the analysis has not been revealed.
The vaccine was developed by the Austrian pharmacist Valenciva and attended the approval process at the Potanan Institute. “Every time a new registered vaccine news arises good news for public health – especially when it includes two basic institutions for SUS: AnVisa and the Butantan Institute. The vacant is always defending life. Ensuring disturbing is the first step to save lives in our country.”
One dose, the damaged vaccine is diluted, IE contains weak microorganisms to stimulate the immune system without causing the disease. Immunity is allowed to apply to population over 18 years and is only invalid for pregnant women, or people with immunodeficiency or immunodeficiency.
More than 68 thousand cases
Chikungunya is transmitted by the affected AEDES AEDES AEDES AEDES – the same that transports dengue and Zika. The virus was identified in Brazil in 2014, and all states have now confirmed cases. Until April 14 this year, the country added 68.1 thousand disease, with 56 deaths.
The main symptoms are sudden start fever (above 38.5 ° C) and severe pain in the feet and hands joints – fingers, ankles and arrests. The disease can also cause headaches, muscle pain and red spots on the skin, and the exacerbation of pre -diseases.
The Ministry of Health at the Ministry of Health said, “Chiconia is a disease that grows in Brazil over the years.
